Amstem

AmStem Inc. is a company registered in Nevada with offices in San Francisco, California, and Seoul, South Korea. The company is a world leader in the field of stem cell research, utilizing stem cells derived from umbilical cords. It holds 19 U.S. and international patents related to stem cell processing, application, and clinical treatment. AmStem owns one of the largest umbilical cord blood stem cell banks in the world, storing over 80,000 units of umbilical cord blood in South Korea. The facility in Korea has received high recognition, including approval from the Korean FDA (KFDA). The cord blood units are processed and stored by the company for unrelated transplants intended for personal storage, as well as for use in home-based transplantation and regenerative medicine. The company is developing a range of cosmeceutical products based on its proprietary stem cell technology and sources its materials from its extensive operations in Korea. AmStem has treated more than 800 individuals in clinical trials, aiming to expand its patent portfolio.